The Netherlands
Disclosure of financial interactions between pharmaceutical companies and healthcare professionals and organisations, and patient organisations can be reported in the Transparency Register Zorg in the Netherlands (www.transparantieregister.nl). Currently, this is only obliged for companies affiliated to certain umbrella organisations and is based on self-regulation. Other companies can disclose their transfers of value voluntarily.
However, in April 2024, the Dutch Minister of Medical Care announced plans to introduce legislation for transparency disclosure. The core principles will remain unchanged to prevent an increased workload for healthcare providers. This applies to the Transparency Register and the annual threshold of €500.
As soon as more information will become available, we will post the updates. Stay tuned…
Source: Stichting Transparantieregister Zorg – Het Transparantieregister Zorg in 2023